Endo International plc (ENDP) saw a big move in the last trading session, as the company’s shares fell by over 10% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent trend for ENDP, as the stock is now down nearly 20% in the past one-month time frame.
On Sep 28, Endo International closed its $8 billion acquisition of Par Pharmaceutical and issued a light third-quarter guidance.
The specialty healthcare company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. However, the consensus for earnings has moved lower in the past month. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
ENDP currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the Medical — Drugs industry may consider a better-ranked stock like Nutraceutical International Corporation (NUTR), carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment